Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$1.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Jun 9 | NTLA | Intellia Therapeutics,… | AGRANT | 9,200 | — | — | +4.4% | Open the original filing on SEC.gov |
| May 27 | KYTX | Kyverna Therapeutics, Inc. | AGRANT◆ | 20,582 | — | — | — | Open the original filing on SEC.gov |
| May 27 | KYTX | Kyverna Therapeutics, Inc. | AGRANT | 5,093 | — | — | +30.6% | Open the original filing on SEC.gov |
| Jan 5 | NTLA | Intellia Therapeutics,… | PBUY | 150,000 | $9.35 | $1.4M | +261.1% | Open the original filing on SEC.gov |
| Jun 13, 2025 | CDNA | CareDx, Inc. | AGRANT | 12,103 | — | — | +8.5% | Open the original filing on SEC.gov |
| Jun 11, 2025 | NTLA | Intellia Therapeutics,… | AGRANT◆ | 11,450 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | NTLA | Intellia Therapeutics,… | AGRANT | 8,000 | — | — | +16.2% | Open the original filing on SEC.gov |
| May 29, 2025 | KYTX | Kyverna Therapeutics, Inc. | AGRANT◆ | 65,351 | — | — | — | Open the original filing on SEC.gov |
| May 29, 2025 | KYTX | Kyverna Therapeutics, Inc. | AGRANT | 16,634 | — | — | — | Open the original filing on SEC.gov |